TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Shanghai Bio-Heart Biological Technology Co., Ltd. Class H ( (HK:2185) ) is now available.
Shanghai Bio-Heart Biological Technology Co., Ltd. has announced an extraordinary general meeting scheduled for February 13, 2025, to discuss several key resolutions. The meeting will address amendments to the company’s business scope, the approval of investment and shareholders agreements, and proposed changes to the articles of association, reflecting a strategic focus on growth and operational enhancement.
More about Shanghai Bio-Heart Biological Technology Co., Ltd. Class H
Shanghai Bio-Heart Biological Technology Co., Ltd. is a company based in the People’s Republic of China, specializing in biological technology. It is listed on the Stock Exchange of Hong Kong and operates within the high-tech sector, focusing on innovative solutions in the biotechnology industry.
YTD Price Performance: -8.54%
Average Trading Volume: 26,992
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$627.8M
See more data about 2185 stock on TipRanks’ Stock Analysis page.